Electrochemical assay for haemoglobin

• US 4,876,205 A
• Filed: 08/12/1987
• Issued: 10/24/1989
• Est. Priority Date: 08/12/1986
• Status: Expired due to Term

• Current Assignee: Generics International Incorporated (Endo International PLC)
• Original Assignee: Medisense Incorporated (Abbott Laboratories Incorporated)
• Inventors: Green, Monika J., Lias, Roger J.
• Primary Examiner(s): Richman, Barry S.
• Assistant Examiner(s): McMahon, Timothy M.
• Application Number:
  US07/084,983
• Time in Patent Office: 804 Days
• Field of Search: 436/66, 356/40-42, 128/637
• US Class Current: 436/66
• CPC Class Codes: G01N 33/721 Haemoglobin

Abstract

A method for the assay of haemoglobin in blood is provided in which the blood is contacted with a sufficient amount of a ferricyanide and the haemoglobin is electrochemically assayed by monitoring the current changes produced on reduction of the ferricyanide by the haemoglobin.

Claims

1. A method for the assay of haemoglobin in blood comprising contacting the blood with a sufficient amount of a ferricyanide so that haemoglobin in the blood is reacted therewith and the haemoglobin is electrochemically assayed by monitoring the current change produced on reduction of the ferricyanide by the hemoglobin.

2. An assay method according to claim 1, wherein the blood is a sample of whole blood or a blood haemolysate sample.

3. An assay method according to claim 1, wherein the blood is provided as an unlysed sample, and the blood is treated with a haemolytic agent.

4. An assay method according to claim 1, wherein the current changes are monitored at a poised potential against a reference electrode.

5. An assay method according to claim 1, wherein the assay is performed using a dry strip sensor containing at least the ferricyanide.

6. An assay method according to claim 5, wherein the dry strip sensor is screen printed with a dry mixture containing finely divided ferricyanide, a surfactant,

7. An assay method according to claim 6 wherein said dry mixture further comprises a buffering agent.

8. An assay method according to claim 1, where said amount of ferricyanide is between 50 and 100 mg per ml of whole blood.